Italian GP Alto Partners has acquired an 80% stake in Italy-based Officina Farmaceutica Italiana (OFI), a family-owned contract manufacturer of dermo-cosmetic and nutritional products, and medical devices.
The GP acquired the stake in the business via its Alto Capital IV fund, which closed on €210m in April this year. The vehicle targets companies generating revenues in the €20-80m bracket.
The partnership will have the objective of fostering product development and help the company expand via acquisitions of smaller companies in the sector. Alberto Donati, the son of OFI's founder, will remain the chairman of the company.
Founded by Attilio Donati in 1946, OFI produces dermo-cosmetic and dietary products, and medical devices, on behalf of third parties and for its own brands.
Based in Bergamo, OFI generates a €18m turnover. According to the Italian online newschannel Be Beez, the group has an EBITDA margin of 16%.
Officina Farmaceutica Italiana – Alberto Donati (chairman).
Transaction is subject to competition authority approval and will mark Ding's third bolt-on in 2020
GP deploys capital from its third fund, which held a €150m final close in 2018 exceeding its target
Ross was previously deputy CIO and joined the company two years ago
Viv Adshead, former president and CEO of Ashfield Communications, agrees to join the IMC board